SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-15-004973
Filing Date
2015-08-31
Accepted
2015-08-31 16:57:39
Documents
1
Period of Report
2015-08-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT gff4_getman083115.html 4  
1 OWNERSHIP DOCUMENT gff4_getman083115.xml 4 7403
  Complete submission text file 0001171843-15-004973.txt   8722
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6923 BELINDER AVE MISSION HILLS KS 66208
Business Address
Getman Daniel P (Reporting) CIK: 0001529207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 151085503